genedrive (LON:GDR) Shares Down 1.3% – Here’s Why

genedrive plc (LON:GDR – Get Free Report)’s share price fell 1.3% during mid-day trading on Friday. The company traded as low as GBX 0.88 and last traded at GBX 0.89. Approximately 1,913,919 shares changed hands during trading, a decline of 63% from the average daily volume of 5,111,255 shares. The stock had previously closed at GBX 0.90.

genedrive Trading Down 1.3%

The company has a market cap of £14.26 million, a price-to-earnings ratio of -1.12 and a beta of 1.00. The company has a debt-to-equity ratio of -120.48, a quick ratio of 5.52 and a current ratio of 0.99. The firm has a fifty day moving average price of GBX 1.12 and a 200 day moving average price of GBX 1.12.

Insiders Place Their Bets

In other news, insider Gino Miele bought 700,000 shares of the stock in a transaction that occurred on Friday, August 28th. The shares were acquired at an average cost of GBX 1 per share, for a total transaction of £7,000. Insiders own 28.09% of the company’s stock.

genedrive Company Profile

(Get Free Report)

genedrive plc is a pharmacogenetic testing company developing and commercialising a low cost, rapid, versatile and simple to use point of need pharmacogenetic platform for the diagnosis of genetic variants. This helps clinicians to quickly access key genetic information that will aid them make the right choices over the right medicine or dosage to use for an effective treatment, particularly important in time-critical emergency care healthcare paradigms. Based in the UK, the Company is at the forefront of Point of Care pharmacogenetic testing in emergency healthcare.

Featured Stories

Receive News & Ratings for genedrive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for genedrive and related companies with MarketBeat.com's FREE daily email newsletter.